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Abstract
The epididymis maintains a state of immune tolerance towards spermatozoa while also protecting them and itself against
infection and acute inflammation. The immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (Ido1) participates in
this delicate local equilibrium. Using the mouse Ido12/2 model, we show here that the absence of IDO1 expression leads in
the epididymis but not in serum to (1) an increase in the inflammatory state as evidenced by changes in the content of
cytokines and chemokines, (2) the engagement of a Th1-driven inflammatory response as evidenced by changes in the
Th17/Treg as well as Th1/Th2 equilibria, as well as (3) differences in the content of lipid intermediates classically involved in
inflammation. Despite this more pronounced inflammatory state, Ido12/2 animals succeed in preserving the local
epididymal immune situation due to the activation of compensatory mechanisms that are discussed.
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Introduction
Tryptophan (TRP) metabolism in mammals via indoleamine
2,3-dioxygenase (IDO) has received considerable attention in
recent years because of its role in modulating both innate and
adaptative immune responses (reviewed in: [1,2]). First described
as an effector of innate immunity, IDO and its associated
kynurenine (KYN) metabolites are now mostly known for
modulating the adaptative immune response, in particular T-cell
mediated responses [1–3]. In most tissues, high KYN production
directly reflects the anti-inflammatory and immunosuppressive
enzyme activity of IDO and thus, the inflammatory and
tolerogenic states of tissues.
In the mouse epididymis, IDO and the KYN pathway are
constitutively activated [4–6]. In previous work we reported that
epididymal IDO1 expression in the mouse is restricted to the caput
region from segments 2 to 5 with a peak of expression in segments
3 to 4 [7]. Both principal and apical cells were shown to be
reactive towards an anti-IDO1 antibody and the enzyme was
shown to be cytosolic and absent from the epididymal luminal
compartment [5,7]. IDO1 is not the sole TRP-recycling enzyme
found expressed in the mouse epididymis epithelium since TDO
(tryptophane 2,3 dioxygenase) and INDOL (or IDO2, an
homologous enzyme coming from a gene duplication event in
mammals) were also shown to be expressed however at much
lower levels [7]. We also demonstrated that IDO1 is the major
contributor to KYN formation in the caput epididymis [7] since
none of the other TRP-recycling enzymes compensated for the
lack of IDO1 either at the transcription level or by their increased
activities in a mouse model invalidated for IDO1, leading to a
drastic drop in KYN content in IDO1-deficient epididymis
extracts [7]. Kynurenine levels in mouse epididymal extracts were
shown to be very significant and, amongst the various downstream
products resulting from IDO1 activity we reported that L-
kynurenine (KYNU), kynurenic acid (KYNA) and 3 hydroxyky-
nurenine (3OHK) were by far the most abundant species following
the caput expression of their corresponding generating enzymes in
the kynurenine pathway [7]. In addition, we have shown that
spermatozoa are capable of triggering Ido1 expression upon
entering the luminal compartment of the epididymis [7]. The
constitutive expression of Ido1 in the proximal adult mouse
epididymis suggested that this region of the organ is permanently
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engaged in both anti-inflammatory and immunosuppressive
actions needed to preserve spermatozoa, which are allogenic
strangers to the male immune system, from auto-immune
responses while maintaining an efficient anti-infection surveillance
of the immune-privileged epididymal duct.
In the present report, we have analyzed in more depth the
immune/inflammatory status of the caput epididymidis in both
WT and IDO1-deficient mice in order to gain further insights into
the role of IDO1 in controlling the balance between immunolog-
ical responsiveness and tolerance.
Materials and Methods
Animals
The present study was approved by the Regional Ethic
Committee in Animal Experimentation (CEMEA-Auvergne;
Authorization CE2-04) and adhered to the current legislation on
animal experimentation in France. Wild type and IDO12/2
BALB/c male mice [8] aged 6 months were used throughout the
study unless otherwise indicated. Mice were housed under
controlled environmental conditions (22uC, 12-h dark period),
fed a basal diet (Global-diet, 2016S, Harlan, Gannat, France) ad
libitum, and given free access to water. Mice were killed by cervical
dislocation under CO2 anaesthesia. Proteins were extracted from
liquid nitrogen-frozen epididymal tissues stored at 280uC until
use. Briefly, tissues were homogenized in 20 mM HEPES, 0.42 M
NaCl, 1.5 m MgCl2 M, 0.2 mM EDTA, 1% NP40, 1 mM
phenylmethylsulfonyl fluoride, 0.1 mM Na3VO4, 0.1 mM NaF
and complete 1X (Roche Diagnostics, Meylan, France). Blood
samples were kept on ice in heparin-coated tubes, centrifuged
15 min at 1500 g at 4uC and then the plasma was recovered and
kept at 280uC until use.
Kynurenine, Tryptophan Determinations
TRP and KYN concentrations were measured by high
performance liquid chromatography (HPLC) using 3-nitro-l-
tyrosine as internal standard [9]. For separation, reversed-phase
cartridges 55-mm LiChroCART RP18 column were used. TRP
was detected by a fluorescence detector at an excitation
wavelength of 285 nm and an emission wavelength of 365 nm.
A Shimadzu (Marne la Valle´e, France) SPD-6A UV-detector in
flow stream series connection was used for detection of both KYN
and nitrotyrosine at a wavelength of 360 nm. The elution buffer
was a degassed potassium phosphate solution (0.015 M, pH 6.4)
containing 5% methanol. Isocratic analyses were carried out at a
flow-rate of 0.8 ml/min and a temperature of 25uC. Frozen serum
and tissue specimens were thawed at room temperature, 200 ml of
samples were diluted with 200 ml of potassium phosphate buffer
(0.05 mol/l, pH 6.0) containing the internal calibrator 3-nitro-l-
tyrosine (100 mmol/l). Protein was precipitated with 50 ml of
trichloroacetic acid (2 M). The capped tubes with the precipitate
were immediately vortex-mixed and centrifuged for 10 min at
13,000 g. One hundred and fifty ml of the supernatants were
transferred into microvials and placed into the autosampling
device. The external calibrator was prepared from freshly thawed
stock solutions of TRP and KYN (1 mM in bidistilled water,
stored at 220uC). Fifty ml of TRP, 10 ml of KYN, and 940 ml of
albumin stock solution were mixed together. Two hundred ml
aliquots of this external calibrator preparation were run through
the entire analytic procedure in parallel with the biological
specimens. Neither degradation of TRP nor production of KYN
were observed in the calibration preparations, and our standards
confirmed the stability of KYN and TRP as compared to protein-
free standard preparations measured without any precipitation
step.
Measurement of Chemokine/Cytokine Levels
Commercially available mouse inflammation antibody arrays
(RayBiotech Inc., Norcross, GA, USA) were used to detect
chemokine and cytokine expressions. Plasma and caput epididy-
mal protein extracts were treated as described by the supplier.
Protein levels were estimated by densitometric analysis of the
membranes. Each set of membranes contains positive and negative
controls that were used for standardization and data are expressed
as relative densitometric values. Chemokine/cytokine evaluations
were performed on 3 biological replicates and 2 technical repeats
were carried out in 3 distinct assays. For statistical analysis,
ANOVA was performed with the factors ‘‘genetic background
[WT vs KO]’’ and ‘‘assays’’ (Statgraphics Plus version 5.1). When
the factor ‘‘genetic background’’ was significant, Fisher LSD tests
(P,0.05) were used. The mean values and standard errors of
mean values are shown on the figures.
Fatty Acids and Sphingolipids Measurements
Total plasma lipids were extracted as described in [10]. The
phospholipid fraction was separated by thin-layer chromatography
on a silica gel plate (Merck, Darmstadt, Germany) and 1-stage
mobile phase development, which consisted of the solvents hexane,
ethylic ether and acetic acid in an 80:20:2 (v/v) ratio. The plates
were dried and sprayed with dichlorofluorescein to visualize
cholesterol esters, phospholipids, triacylglycerols, and free fatty
acid bands under ultraviolet light. The phospholipid band was
scraped off into a separate test tube, and the fatty acids were
converted into methyl esters. Fatty acid methyl esters were
prepared and analyzed as previously described [11]. Ceramide
and sphingomyelin analyses were performed at the lipidomic
platform (INSERM IFR150 Metatoul Platform, Toulouse, France)
as follows: cells were homogenized in methanol/EGTA 5 mM
(2:1 v/v) with a FAST-PREP apparatus (MP Biochmicals), and an
aliquot was taken up for protein measurement. Total lipids were
extracted in chloroform/methanol/5 mM EGTA (2.5:2.5:2.1, v/
v/v) in the presence of the internal standard stigmasterol (18 mg)
as described in [12]. Ceramide-NC15 (2 mg), was prepared
according to [13]. The lipid phase was dried down under a
nitrogen ux, and lipid extract was submitted to a mild-alkaline
treatment in 1 ml methanolic NaOH 0.6 N, followed by silylation
in BSTFA (N,O-bis(trimethylsilyl)trifluoroacetamide ) containing
1% TMSCl (Chlorotrimethylsilane)/acetonitrile (1:1, v/v) [13].
The mixture (5 ml) was directly analysed by gas-liquid chroma-
tography on a 4890 Hewlett Packard (Palo Alto, CA, USA) system
using a RESTEK RTX-50 fused silica capillary columns (30 m
60.32 mm, 0.1 mm film thickness) [13]. Oven temperature was
programmed from 195uC to 310uC at a rate of 3.5uC per min (for
12 min), and the carrier gas was hydrogen (0.5 bar). The injector
and the detector were at 310uC and 340uC, respectively. SM and
ceramide were separated on the basis of the number of carbons
and the unsaturation of the amide-linked chain and quantified
according to the internal standard. C16, C18, C22 and C24 SM or
ceramide refer to the sum of the molecular species having this
number of carbons in the lateral chain, independent of the
unsaturation. Results are given as nmol per mg protein.
Quantitative Reverse Transcriptase Polymerase Chain
Reactions
Total RNAs were isolated with the NucleoSpinH RNA II kit
(Macherey-Nagel, France) and were reverse transcribed by M-
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MLV Reverse Transcriptase (Promega Corp., France) according
to the manufacturer’s instructions. Quantitative real time PCR
assays were performed using a RealPlex thermocycler (Eppendorf).
Two ml of diluted cDNA template (1/20) were amplified using
MESA GREEN qPCR MasterMix Plus (Eurogentec, France)
according to the manufacturer’s instructions. Primer sequences are
given in Table 1 and amplification efficiencies are provided. To
ensure no genomic DNA contamination primers were designed in
distinct exons separated by at least 500 bp-introns, so that the
genomic DNA cannot be amplified. A standard curve of
amplification efficiency for each set of primers was generated
with a serial dilution of plasmids containing DNA of targeted
genes. Melting curve analysis was carried out to confirm the
specificity of primers. For quantification of transcripts, the relative
method was used to calculate mRNA relative level to Cyclophilin B
standard which was chosen because it has a stable expression
between the tissues and genotypes.
Western Blots
Proteins (40 mg) were separated by SDS-PAGE and transferred
onto nitrocellulose membrane (Hybond ECL, GE Healthcare
Biosciences, Piscataway, NJ). Blots were blocked with 10% low-fat
dried milk/0.1% Tween 20/Tris Base Salt (TBS) and probed
overnight at 4uC with anti-GAPDH (1/5000, Sigma-Aldrich) for
loading controls and in parallel with various primary antibodies.
For monitoring the activation of the STAT protein family,
antibodies came from the STAT/Phospho-STAT antibody
sampler kit (Cell Signaling, Ozyme, Saint-Quentin en Yvelines,
France). For monitoring the activation of the Smad intracellular
effectors, rabbit monoclonal anti-mouse Smad1, rabbit monoclo-
nal anti-mouse Smad3, rabbit polyclonal anti-mouse Smad5 as
well as their coreesponding rabbit monoclonal anti-mouse
phospho-Smad1/5 and phospho-Smad3 (Cell Signaling, Ozyme,
Saint-Quentin en Yvelines, France) were used. Each primary
STAT (STAT1-3-5-6), Phospho-STAT (P-STAT1[Tyr701], P-
STAT3[Ser727], P-STAT5[Tyr694] and P-STAT6[Tyr641]),
Smad (Smad 1-3-5) and Phospho-Smad (P-Smad1/5 [Ser463/
465] and P-Smad3 [Ser423/425]) antibody was used at a dilution
of 1/1000 in 1X TBS-Tween 5%. The secondary antibody was a
goat anti-rabbit horseradish peroxidase conjugate (1/5000, GE
Healthcare, UK) that was detected using the ECL Western
Blotting Detection kit on HyperfilmTM (GE Healthcare). Densi-
tometric analyses were carried out with ‘‘Quantity one’’ software
(Bio-Rad, Marnes-la-Coquette, France).
Fluorescence-Activated Cell Sorting Analyses
Caput epididymides were dissected and processed for the
preparation of stroma-vascular fractions (SVF) as described in [14]
Caspar-Bauguil et al. (2005). Briefly, tissues were digested in
phosphate buffer saline (PBS) containing 2% bovine serum
albumin (BSA) and 2 mg/ml collagenase (type II collagenase,
Sigma-Aldrich, St. Quentin Fallavier, France) for 30 min at 37uC.
Digested tissues were filtered through a 25 mm nylon membrane
and tissue samples were centrifuged (600 g for 10 min) to generate
SVFs. Cells were washed in PBS-5% FCS (fetal calf serum,
Invitrogen, Cergy-Pontoise, France). Red cells were lysed in a
buffer containing 155 mM ammonium chloride, 20 mM Tris,
pH 7.6, for 5 min. Cells were then centrifuged (600g for 10 min)
and re-suspended in PBS before counting on a Coulter counter
(Beckman-Coulter, Roissy, France). Fluorescein (FITC)- or Phy-
coerythrin (PE) conjugated anti-cluster of differentiation 3 (CD3),
CD4, CD8, CD19 antibodies were used (Miltenyi, France). Cells
(around 26105/sample) were stained in PBS containing 5% mouse
serum and incubated with conjugated anti-mouse monoclonal
antibodies for 20 min at room temperature in the dark. Cells were
washed in PBS and then analyzed on a fluorescence-activated cell
sorter (FACS; FacsCalibur, Becton Dickinson Biosciences,
France). Subpopulations of lymphocytes were identified by
Table 1. Oligonucleotides used in the course of the study.
Gene product Primer sequences (5=.39) Insert length Tm in uC Efficiency
Rorc
NM_011281.2
Fw AGCAGTGTAATGTGGCCTAC 179 bp 59uC 0.9886
Rv GCACTTCTGCATGTAGACTG
FoxP3
NM_001199348.1
Fw CCCAGGAAAGACAGCAACCTT 90 bp 59uc 0.9778
Rv TTCTCACAACCAGGCCACTTG
Cyclophilin b
NM_011149.2
Fw GGAGATGGCACAGGAGGAA 76 bp 55 to 63uC 0.9741
Rv GCCCGTAGTGCTTCAGCTT
Gata-3
NM_008891.3
Fw ACGGAAGAGGTGGACGTACT 242 bp 58uC 0.9905
Rv GTGGTGGATGGACGTCTTG
T-bet
NM_019507.2
Fw GTTCCCATTCCTGTCCTTC 211 bp 60uC 09741
Rv CCTTGTTGTTGGTGAGCTT
Cox1
NM_008969.3
Fw CATGGCTGGCCTAGAACTCACT 72 bp 63uC 0.9923
Rv AAGGCAGAGAGCAGTTGCATCT
Cox2
NM_011198
Fw CCAGCACTTCACCCATCAGTT 52 bp 63uC 0.9868
Rv ACCCAGGTCCTCGCTTATGA
doi:10.1371/journal.pone.0066494.t001
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appropriate marker combinations and light scatter properties.
Data acquisition was performed with Cell Quest software (Becton
Dickinson = BD) while data analysis was done using BD Diva
software.
Statistical Analyses
Kruskal-Wallis and Mann-Whitney tests were performed with
GraphPad Prism 5.02 software to determine the significance of
differences between samples. P values #0.05 were regarded as
significant.
Results
The KYN:TRP ratio (KTR) is commonly used as an indicator
of the activation of the KYN pathway [15]. As shown in Figure 1A,
the KTR in wild-type caput epididymal extracts is about two
orders of magnitude higher than in corresponding plasma samples.
This confirms that in wt animals the mouse caput epididymidis is
in a special immune/inflammatory state compared to the systemic
compartment. By contrast, in Ido12/2 animals, the KTR in the
caput epididymis does not differ from that in plasma, suggesting
that IDO1 is the major provider of KYN in the former tissue. To
monitor the inflammatory status of the caput epididymis, we
measured the classical pro-inflammatory cytokines TNF-a and
INF-c in both wt and Ido12/2 caput epididymal extracts. As
depicted in Figure 1B, in the absence of IDO1 these cytokines
were significantly up-regulated in caput epididymal extracts, while
plasma levels did not differ significantly between wt and Ido12/2
animals. The up-regulation of these cytokines in the caput
epididymidis of Ido12/2 animals suggests an aggravated inflam-
matory state. This is supported by the fact that caput epididymidal
extracts of Ido12/2 animals also contained higher levels of the
soluble TNF receptors sTNF-RI and sTNF-RII compared to wt
extracts (Fig. 1C) which are often seen as classical counteractive
phenomena to diminish TNF-a-mediated pro-inflammatory sig-
nal. The increase in the inflammatory status of the Ido12/2 caput
epididymidis was further confirmed by the observation, that
several inflammatory chemokines including CCL3 (MIP-1a),
CCL5 (RANTES), CCL11 (Eotaxin-1), CCL24 (Eotaxin-2),
CCL25 (TECK), CXCL9 (MIG), CXCL11 (I-TAC), and
CX3CL1 (Neurotactin) were also up-regulated in Ido12/2 caput
epididymidal extracts as shown in Figure 2A. The up-regulation of
these chemokines was confined to the caput epididymidis, as the
corresponding plasma levels were not elevated (Fig. 2B). The
specificity of the epididymal response is further attested by the fact
that amongst the various chemokines surveyed not all of them
were up-regulated. For instance, the concentrations of CCL1
(TCA-3), CCL2 (MCP1), CXCL5 (LIX) and CXCL13 (BCA-1)
were not elevated in caput epididymal extracts of Ido12/2 animals,
and two of them, namely CCL2 (MCP1) and CXCL5 (LIX), were
found to be even down-regulated in the corresponding plasma
samples (Fig. 2A and 2B, right bars).
Other Indicators of Ido12/2 Caput Epididymis
Inflammatory Status
Inflammatory situations are commonly accompanied by an
increase in the mobilization of lipid mediators such as eicosanoids
that have both anti- and pro-inflammatory actions [16]. During
inflammatory processes part of these eicosanoids are the result of
cyclooxygenase activity, essentially the inducible (upon inflamma-
tion) cyclooxygenase 2 (COX2), which metabolizes arachidonic
acid released from membrane phospholipids. In Figure 3A, we
show that the accumulation of both COX1 and COX2 transcripts
is more pronounced in caput epididymal extracts of Ido12/2 than
in wt controls confirming the more pronounced inflammatory
situation of the Ido12/2 caput epididymis. Since arachidonic acid
consumption by COX enzymes is classically accompanied by a
distortion of the free fatty acid profiles we have looked at the free
fatty acid contents in both Ido12/2 and wt caput epididymal
extracts. In agreement with the increase in COX expression,
concentrations of all the v6 and v3 lipidic intermediates (leading
to prostaglandins, leukotrienes & thromboxanes) were significantly
reduced in Ido12/2 caput epididymidis extracts compared to wt
(Fig. 3B). Reflecting classical pro-inflammatory situations we
observed a change in the v6/v3 ratio in caput epididymidis
extracts of Ido12/2 animals in favor of the v6 series [17]. In
addition, we observed that the SCD (stearoyl-CoA desaturase)
ratio (16:1n-7/16:0) is 3-fold higher in Ido12/2 than in wt caput
epididymidis extracts and that the levels of unsaturated fatty acids
were also increased, both parameters constituting classical signs of
inflammation [18]. Finally, amongst other lipid intermediates that
are known to be associated with inflammation [19], increased
levels of sphingolipids/ceramides were also seen in caput
epididymal extracts of Ido12/2 animals when compared to wt
(Fig. 3C).
Impact of IDO-deficiency on T Cell-mediated Responses
in the Caput Epididymis
Both KYN production and tryptophan depletion resulting from
IDO activity are known to specifically control the activation and
differentiation of T-cell subpopulations [20]. To verify whether
IDO1 deficiency affects T cell-mediated responses in the caput
epididymidis, we monitored the expression of various interleukins
associated with T-cell differentiation and activation. It is obvious
from Figure 4A that, with the exception of IL-4, all other T cell-
related cytokines monitored including IL-1ß, IL-2, IL-3, IL-6, IL-
9, IL-10, IL-12p70, IL-12p40p70, IL-13, and IL-17 were
significantly up-regulated in Ido12/2 caput epididymal extracts.
In plasma, on the other hand, with the single exception of IL-4, no
significantly increased lymphokine levels were observed (Fig. 4B).
These data suggest that a T-cell response is engaged in the caput
epididymidis of Ido12/2 animals, which is further supported by
significantly increased concentrations of GM-CSF and G-CSF in
the epididymis of Ido12/2 animals, two colony-stimulating factors
known to be produced by T cells, (Fig. 4C).
IDO1 Deficiency in the Caput Epididymidis Alters the
Th17/Treg/Th1/Th2 Equilibrium
Depletion of tryptophan via IDO activity as well as KYN actions
have been shown to induce the differentiation of naı¨ve T cells into
the Treg lineage [21]. The latter is characterized by its
immunosuppressive effect mediated by its ability to secrete
immunomodulatory cytokines such as IL-10 and TGFß1 [22].
Both cytokines in return slow down the differentiation of the
Th17/Th1/Th2 inflammatory subpopulations [23]. Thus, IDO
activity influences the Th17/Treg equilibrium in favor of Tregs,
allowing immunosuppressive actions and the creation of a
tolerogenic situation (Fig. 5A). To evaluate whether this Th17/
Treg equilibrium has been modified in caput epididymal tissue
from Ido12/2 animals we used Western blot and real-time PCR to
respectively monitor, the STATn-dependent signal transduction
pathways and the accumulation of key transcription factors that
specifically govern Th17 and Treg differentiation from naı¨ve T
cells. Figures 5B and 5C show significant increases in the
phosphorylation status of the STAT3 signal transducer interme-
diate and in the expression of the Th17-lineage specific
transcription factor RORc, respectively, in Ido12/2 caput tissue
Ido1 and Mouse Epididymis Immune Status
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extracts as compared to wt extracts. In the same samples we
observed neither a change in the phosphorylation status of STAT5
nor in the expression of the FOXP3 transcription factor, both of
which are specific for the Treg lineage differentiation program.
These data suggest that in caput epididymal extracts of Ido12/2
animals the Th17/Treg equilibrium is altered in favor of the Th17
subpopulation.
As increased representation of the inflammatory Th17 subpop-
ulation in Ido12/2 caput epididymis should affect the Th1/Th2
equilibrium [23] we show in Figures 6A-B that the Th1-lineage
specific transcription factor T-bet was significantly up-regulated in
Figure 1. Analysis of the inflammatory status of the epididymis. A: KYN:TRP ratios in caput epididymis and blood plasma, respectively, of 6
month-old wt and IDO12/2 animals. The Y-axis is a semi logarithmic representation in mmole/mmole. B: Histograms show the levels of INF-c and
TNF-a in caput epididymidis extracts and plasma from 6 month-old wt and IDO12/2 animals. C: Histogram shows the levels of the soluble TNF
receptors (sTnfRI and sTnfRII) in caput epididymidis extracts from 6 month-old wt and IDO12/2 animals. *P#0.05, **P#0.01, ***P#0.001.
doi:10.1371/journal.pone.0066494.g001
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caput epididymal extracts of Ido12/2 animals, while expression of
the Th2-lineage specific transcription factor GATA-3 did not
change. These data support the notion that the caput epididymis
of Ido12/2 animals is engaged in a Th1 response. Consistent with
this hypothesis, a significant increase in the leptin content of caput
epididymal extracts from Ido12/2 animals was found, while
plasma levels did not differ significantly from those of wt animals
(Fig. 6C). Leptin is known to prime the generation of pro-
inflammatory adaptative Th1 responses after TCD4+-cells have
encountered antigens following their interaction with antigen
presenting cells (APC) [24,25].
IDO1 Deficiency does not Alter the Overall Leucocyte
Representation in Caput Epididymis
FACS analysis was used to look at the distribution of leucocytes
in caput epididymis tissue samples dissociated by collagenase
treatment in both wt and Ido12/2 animals. Figure 7 shows
cytofluorometric analyses of gated lymphocyte subpopulations in
wt and Ido12/2 caput epididymis samples (n = 5). Globally there is
no dramatic change in the representation of the various leucocyte
lineages that we have been able to monitor in the different issue
extracts. In addition, the analysis revealed that B cells and CD3+
cells were quite rare in the caput epididymal tissue, whatever the
genetic background, and that most of the lymphoid cells were
triple negative (CD32/CD42/CD82) cells. Regarding the few
CD3+ cells, they were essentially found to be of the CD3+ double
negative type (devoid of CD4 and CD8), the so-called CD3+DN or
TDN.
Discussion
The present data indicate that IDO1 and its downstream
metabolites, the KYNs, participate in the establishment of an
immunological equilibrium within the caput epididymis of mice.
This is supported by our observations that in the absence of IDO1
expression (i.e., in the Ido12/2 mouse model [8]) an increase in the
concentrations of classical inflammatory cytokines (IFN-c, TNF-a,
IL-6, IL-1ß) as well as in various chemokines associated with T
cell-driven inflammatory situations was seen, but solely in caput
epididymidis extracts and not in plasma. A change in the
Figure 2. Chemokine profiles of the epididymis and plasma. Histograms show the levels of the inflammatory chemokines CCL1 (TCA-3, T-cell
activation 3), CCL2 (MCP1, Monocyte chemoattractant protein 1), CCL3 (MIP-1a, Macrophage inflammatory protein 1), CCL5 (RANTES, regulated on
activation normal T cell expressed and secreted), CCL11 (Eotaxin 1), CCL24 (Eotaxin 2), CCL25 (TECK, Thymus-Expressed Chemokine), CXCL5 (LIX,
Lipopolysaccharide-induced CXC-chemokine), CXCL9 (MIG, Monokine induced by gamma interferon), CXCL11 (I-TAC, Interferon-inducible T-cell alpha
chemoattractant), CXCL13 (BCA-1, B-cell attracting chemokine 1) and CX3CL1 (Neurotactin) in caput epididymidis extracts (A) and plasma (B) from 6
month-old wt and IDO12/2 animals. *P#0.05; **P#0.01.
doi:10.1371/journal.pone.0066494.g002
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Figure 3. Other inflammatory markers of the IDO12/2 caput epididymidis. A: Quantitative RT-PCR estimations of COX1 and COX2 mRNA
accumulation in caput epididymidis samples from wt (black bars) and IDO12/2 (grey bars) male mice. For quantification of transcripts, the relative
method was used to calculate mRNA levels relative to Cyclophilin B standard. WT levels were set as 1 in the Y-axis. Mean +/2 SEM; n = 12. *P#0.05;
**P#0.01. B: Schematic representation of the omega 6- (v6) and omega 3-derived (v3) fatty acid (FA) intermediates (DGLA, Dihomo-gamma-linolenic
acid; AA, Arachidonic acid; EPA, Eicosapentaenoic acid and DHA, Docosahexaenoic acid) precursors of the eicosanoids derivatives including
prostaglandins, leucotrienes and thromboxanes. Bracketed numbers given above each FA species indicate difference recorded in the representation
of these FA in caput epididymidis extracts of IDO12/2 animals versus wt (n = 6). C: Histograms illustrate the recorded differences in sphingolipid
intermediates (sphingomyelin and ceramides) concentration in caput epididymidis extracts of wt (black bars) and IDO12/2 (grey bars) from 6 month-
old animals. Cholesterol level was taken as a reference to show that the transgenic animals do not present a general disruption in their epididymal
lipidic profile.
doi:10.1371/journal.pone.0066494.g003
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inflammatory status of the caput epididymidis in Ido12/2 animals
was also indicated by the up-regulation of several T cell-generated
lymphokines and the over-expression of the inflammation-induced
cyclooxygenase, COX2. As expected, COX2 induction in the
epididymis of Ido12/2 animals was associated with increased
consumption of v3- and v6-PUFA, which serve as precursors for
Figure 4. Interleukin profile of the epididymis. Histograms show the levels of the interleukins IL-1ß, IL-2, IL-3, IL-4, IL-6, IL-9, IL-10, IL-12p70, IL-
12p40p70, IL-13, and Il-17 in caput epididymidis extracts (A) and plasma (B) from 6 month-old wt and IDO12/2 animals. *P#0.05; **P#0.01.
doi:10.1371/journal.pone.0066494.g004
Ido1 and Mouse Epididymis Immune Status
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e66494
both pro-inflammatory and anti-inflammatory effectors including
prostaglandins, leukotrienes and thromboxanes [16]. In addition,
we show here an increase in the sphingolipid/ceramide pathway in
caput epididymidal extracts of Ido12/2 animals (Fig. 3C) that may,
in part, explain the activation of COX2, because sphingolipids and
particularly ceramides have been shown to actively participate in
TNF-a-mediated inflammatory responses (for a recent review see:
[19]). It is worth noting that the epididymis is rather unusual in
this regard as it is characterized by its constitutive expression of
COX2 [26,27]. In any other tissue, COX2 expression is solely
induced by inflammatory stimuli. The constitutive expression of
both COX2 and IDO1 reinforces the idea that the caput
epididymidis is characterized by the maintenance of a permanent
immune-tolerant state. We show here that both COX1 and
COX2 expression levels were upregulated in Ido12/2 caput
extracts compared to wt. Although it is commonly believed that the
constitutive isoform COX1 has little or no involvement in
regulating immune responses [28], there are recent reports
Figure 5. Th17/Treg equilibrium in the caput epididymidis. A:
Differentiation of the Th17 and Treg lineages from naı¨ve T cells are
mutually exclusive via their respective cytokines. STAT3/RORc drive the
differentiation of Th17 cells, while STAT5/FOXP3 drive the differentia-
tion of Treg. In inflammatory or/and tolerogenic situations, IDO1 activity
and the resulting KYNs promotes the differentiation of Treg cells and
their immunosuppressive actions. B: Representative western blots
showing the levels of STAT3 and STAT5 proteins and their phosphor-
ylated counterparts phosphoSTAT3 and phosphoSTAT5 upon activation
in caput epididymidis extracts from wt and IDO12/2 mice at 6 months
of age. Bar graphs display means 6 SEM using GAPDH as an internal
standard for quantification. (n = 7 for Stat3, and n = 3 for Stat5;
**p,0.01). C: Quantitative RT-PCR estimations of RORc and FOXP3
mRNA accumulations in caput epididymidis samples from wt (black
bars) and IDO12/2 (grey bars) male mice. For quantification of
transcripts, the relative method was used to calculate mRNA relative
level to Cyclophilin B standard. WT levels were set as 1 in the Y axis.
Mean +/2 SEM; n = 12. **P#0.01.
doi:10.1371/journal.pone.0066494.g005
Figure 6. Th1/Th2 equilibrium in the caput epididymidis. A:
Differentiation of the Th1 and Th2 lineages from naı¨ve T cells are
mutually exclusive via their respective cytokines. T-bet drives the
differentiation of Th1 cells while Gata-3 drives the differentiation of Th2
cells. B: Quantitative RT-PCR estimations of T-bet and Gata-3 mRNA
accumulation in caput epididymidis samples from wt (black bars) and
IDO12/2 (grey bars) male mice. For quantification of transcripts, the
relative method was used to calculate mRNA levels relative to
Cyclophilin B standard. WT levels were set as 1 in the Y-axis. Mean +/
2 SEM; n = 12. **P#0.01. C: Histograms show the levels of leptin in
caput epididymidis extracts and plasma from 6 month-old wt and
IDO12/2 animals. **P#0.01.
doi:10.1371/journal.pone.0066494.g006
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suggesting that COX1 is actively involved in immunoregulation
[29] and that part of its effect is mediated via IL-17 production by
Th17 cells [30]. Our data are consistent with these statements
since we observed a shift in the Th17/Treg equilibrium towards
Th17 cells and an associated increase in the concentration of IL-
17, in the caput epididymides of Ido12/2 animals.
Figure 7. Flow cytometry analysis of lymphocytes populations amongst wt and Ido12/2 caput epididymal cells. Cytogrammes show
the gating strategy used to identify the different lymphocytes subpopulations. The lymphocyte gate was defined according to cell size (FSC) and
granularity (SSC) criteria. The two tables show the number of cells (events) for each population gate in wt (left) and Ido12/2 (right) animals. They also
show the proportion of each population among all acquired cells (% total).
doi:10.1371/journal.pone.0066494.g007
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Given the recent report that the mouse epididymal duct, and
especially the caput region is lined with antigen presenting
dendritic cells [31], it is expected that an increased inflammatory
situation, as it is the case in Ido12/2 animals, will exacerbate
sperm-antigen presentation in the caput. In this process, antigen
presenting cells (APC) and the cytokine environment prime
directly and indirectly naı¨ve T cells to differentiate into various
cell subtypes known as Th1, Th2, Th17 and Treg. The
equilibrium in these various T-cell subpopulations is exquisitely
regulated through mutually exclusive cytokine-mediated paracrine
regulations with the reciprocal inhibition of Th1 and Th2 on one
side and of Th17 and Treg on the other side, as well as the general
inhibition of the Treg population over the inflammatory Th17,
Th1 and Th2 populations [32]. IDO activity has clearly been
reported to be an inducer of the Treg differentiation pathway, thus
partly explaining its immunosuppressive actions and the creation
of tolerogenic states in situations where IDO is upregulated [33]. It
was therefore expected, that lack of IDO1 expression in the caput
epididymidis territory would promote the differentiation of the
Th17 subpopulation. In the absence of an easy way to appreciate
quantitatively the caput epididymal Th17 subpopulation we show
here that the factors that promote the Th17 differentiation (ie,
STAT3 and RORc) are up-regulated in the Ido12/2 caput
extracts.
Chemokines and Cytokines Production in Caput
Epididymidis of Ido12/2 Animals Argue for a Th1-driven T
Cell Response
Concerning the chemokine/cytokine status, it is interesting to
note that amongst the up-regulated chemokines in Ido12/2 caput
epididymal extracts we found CCL3 (MIP-1a) and CCL5
(RANTES). Both promote development of IFN-c-producing Th1
lymphocytes directly or indirectly by increasing IL-12 production
by APCs [34]. Accordingly, IL-12 and IFN-c levels were also
increased in the caput epididymis of Ido12/2 animals. In addition,
levels of IFN-c-mediated CXC chemokines including CXCL9
(MIG), CXCL11 (ITAC) and CX3CL1 (Neurotactin) were also
elevated in the caput epididymides of Ido12/2 animals. These
chemokines are known to recruit Th1 lymphocytes during
inflammatory processes [34–36]. Taken together, these observa-
tions suggest that the chemokine/cytokine environment of the
caput epididymidis of Ido12/2 animals is that of a Th1-based
response. This conclusion is reinforced by the observation that
amongst the chemokines and cytokines that remained unaltered in
the caput epididymides of Ido12/2 animals were CCL2 (MCP1)
and IL-4. The latter is the classical Th2 cytokine, whereas CCL2 is
known to inhibit the production of IL-12 and to enhance the
production of IL-4 by activated Th2 cells [37]. Our conclusion
that lack of IDO1 expression triggers a Th1-driven cellular
immune response in the caput epididymidis is also supported by
our observations that Th1-specific cytokines (IL-2, TNF-a and
IFN-c) were found at higher levels in caput epididymal extracts of
Ido12/2 than in wt animals. Increased leptin levels in caput
epididymis extracts of Ido12/2 animals also support a Th1
response, as leptin has been shown to stimulate the Th1 pro-
inflammatory cellular immune response [24,25]. Leptin has also
been shown to play pro-inflammatory and immunomodulatory
roles in various autoimmune diseases characterized by Th1
autoreactivity [38,39]. Finally, concurring with the cytokine/
chemokine Th1 profile, the Th1 cell-specific transcription factor,
T-bet, is up-regulated in Ido12/2 caput epididymal extracts.
Altogether, these observations support the idea of an inflammatory
Th1-mediated cellular immune response in the caput epididymis
of Ido12/2 animals. Promotion of a Th1 response in the
epididymis of Ido12/2 animals is expected in the context of a
weaker immune-tolerant environment against sperm antigens that
should stimulate a Th1-driven autoimmune reaction [40]. In
addition, it has been reported that kynurenines including 3-
hydroxy-arachidonic acid (3-OH-AA) and 3-hydroxykyurenine
(3OHK) inhibit the actions of Th1 cells and enhances the action of
Th2 cells [41]. Other reports have shown that stimulation of IDO
activity in dendritic cells diminishes Th1 response [42]. Converse-
ly, it was also reported that 1-methyltryptophan-mediated
inhibition of IDO activity enhances Th1-associated inflammation
[43]. Therefore, in the absence of IDO1 and its downstream
metabolites, as it is the case in the epididymis of the Ido12/2
animals [7], one should expect a shift of the Th1/Th2 equilibrium
towards Th1. This behaviour in agreement with the hypothesis
that the immunosuppressive action of IDO and its role in inducing
immune tolerance is ensured by its inhibitory effect on the Th1
subpopulation [40].
Caput Epididymidis of IDO1-deficient Animals Copes
with Increased Local Inflammation and Avoids
Compromise of its Immune-tolerant Status Towards
Spermatozoa
We have shown above that IDO1 deficiency promotes
inflammation in the caput epididymidis via a shift in both Th17/
Treg and Th1/Th2 balances, respectively, in favor of Th17 and
Th1 pro-inflammatory T cells. However, this situation does not
lead to acute inflammatory conditions such as leucocytospermia
and granulomas. This suggests that compensatory mechanisms are
at work to maintain the immune balance of the epididymis in
Ido12/2 animals. In confirmation of this status quo situation, our
preliminary investigations via FACS analyses showed that the
caput epididymal leucocyte distribution is not modified when wt
animals were compared to Ido12/2 (Fig. 7). In agreement with
previous reports it also showed that most of the lymphoid cells
were triple negative (CD32/CD42/CD82) meaning that they
could be either dendritic cells (DC) or of the natural killer (NK)
lineage and that B cells and CD3+ lymphoid cells were scarce [44].
It is interesting to note that the CD3+ cells were found to be mostly
of the CD3+ double negative type (devoid of CD4 and/or CD8),
the so-called CD3+DN or TDN which have been added recently to
the increasing list of T cells that exert T regulatory functions
Figure 8. Monitoring of the activation of the TGFß/BMP
pathway in caput epididymis extracts. Bar graphs showing the
levels of Smad3 and Smad1-5 proteins and their phosphorylated
counterparts phosphoSmad3 and phosphoSmad1-5 upon activation in
caput epididymidis extracts from wt and IDO12/2 mice at 6 months of
age. Bar graphs display means 6 SEM using GAPDH as an internal
standard for quantification (n = 4 for Smad3, and n = 8 for Smad1-5;
*P#0.05; **p,0.01).
doi:10.1371/journal.pone.0066494.g008
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similar to those of classical Treg (CD4+CD25+FoxP3+) cells [45–
49]. Especially, TDN were very recently shown to be involved in
the prevention of autoimmune responses engaged in the inflamed
epididymis after vasectomy [50].
Other non-exclusive hypotheses can be brought forward to
explain the new immune equilibrium found in the caput
epididymis of the IDO1-deficient animals and the preservation
of the tolerogenic environment towards spermatozoa. First, we
show here that despite the absence of IDO1 expression and its
known inducing effect on the Treg lineage [51], the differentiation
of the Treg subpopulation is not dramatically reduced in the
epididymis of Ido12/2 animals. Beside the IDO1/KYN pathway,
the immunosuppressive factor TGF-ß1 was shown to act as a Treg
autocrine inducer [52]. It is worth noting that via comparative
gene expression array analyses (not shown) we revealed Bmp8a to
be among the genes most strongly induced in Ido12/2 caput
epididymides. BMP8a belongs to the TGF-ß family and was
shown previously to participate in the differentiation of the caput
epididymal epithelium [53,54]. Interestingly, lack of BMP8a and
BMP7 expression in Bmp8a2/2 and Bmp8a/Bmp72/2 mice
provoked inflammatory situations in the caput epididymides of
these animals characterized by the occurrence of sperm-mediated
granulomas [54]. These observations support the idea that a TGF-
ß family member such as BMP8a might participate in the immune
control of the adult caput epididymidis. It is thus possible that
through an anti-inflammatory autocrine/paracrine signaling
cascade involving the TGF-ß/BMP/activin pathway the Ido12/2
epididymal epithelium partly recovers its immune balance by
maintaining the Treg population or by negatively controlling the
expansion of the Th17 sub-lineage. This hypothesis is supported in
the present study by our preliminary observation that in Ido12/2
caput epididymidis extracts the SMAD3 intracellular effector of
the TGF-ß pathway is activated (Fig. 8). Which cell type(s) in the
epididymis epithelium is (are) involved in that phenomenon
remains to be clarified. Secondly, the increase in the immuno-
suppressive cytokine, IL-10, we observed in the Ido12/2 caput
extracts may also participate in the new immune equilibrium.
Although Treg is the major provider of IL-10, it has been shown
that several other cell types can also produce it; including Th1,
Th2, cytotoxic T cells, B lymphocytes, mast cells, mononuclear
phagocytes, APCs as well as TDN cells [34,55]. More investigations
will be necessary to identify which cell(s) type(s) in the caput
epididymis of Ido12/2 animals is responsible for the increased
production of IL-10. Thirdly, the earlier reported 50% decrease in
proteasomal activity in Ido12/2 caput extracts [7] may constitute
yet another regulatory anti-inflammatory process to diminish both
the production of inflammatory cytokines and, MHC-mediated
antigen presentation in chronic inflammatory situations as it has
been suggested elsewhere [56,57].
In conclusion, we have shown here that IDO1 plays a role in
maintaining the unusual immune balance that characterizes the
caput epididymidis. In the absence of IDO1 expression, local
inflammation is promoted by the engagement of a Th1-driven T-
cell response as expected when autoimmunity is stimulated.
Despite the absence of this immunosuppressive player the
epididymis of the Ido12/2 mice copes with the pro-inflammatory
situation and maintains immune-tolerance. Our data suggest that
TGF-ß signaling, IL-10 up-regulation and impairment of caput
epididymis proteasomal activity may represent means by which
the epididymis of Ido12/2 animals restores its immune balance.
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